Felipe Villacampa

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Journal: BJU international

Published: March 03, 2026

First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies.

First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies.

Journal: Clinical genitourinary cancer

Published: November 10, 2023

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.

Journal: European urology open science

Published: March 30, 2022

BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.

BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.

Journal: European urology

Published: February 21, 2022

miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma.

miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma.

Journal: PloS one

Published: December 05, 2019

Recommendations for the management of renal involvement in the tuberous sclerosis complex.

Recommendations for the management of renal involvement in the tuberous sclerosis complex.

Journal: Nefrologia

Published: April 23, 2019

Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status.

Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status.

Journal: Scientific reports

Published: February 22, 2019

Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.

Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.

Journal: Nature medicine

Published: June 15, 2018

The role of chemotherapy in the treatment of hormone sensitive metastatic prostate cancer.

The role of chemotherapy in the treatment of hormone sensitive metastatic prostate cancer.

Journal: Archivos espanoles de urologia

Published: April 11, 2018

CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status.

CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 03, 2018

Urothelial cancer proteomics provides both prognostic and functional information.

Urothelial cancer proteomics provides both prognostic and functional information.

Journal: Scientific reports

Published: July 14, 2017

BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer.

BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 06, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026